肥胖是狼性炎的一个独立的不良预后因素
Francy Cuervo1,2, Antoine Enfrein1, Hans-Joachim Anders3
1Department of Rheumatology, Cliniques Universitaires Saint-Luc, Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, UCLouvain, Brussels, Belgium.
Lupus
|September 17, 2025
概括
肥胖 (体重指数≥30kg/m2) 是狼性炎 (LN) 中慢性病G3 (CKD G3) 的重要危险因素. 体重管理对于改善LN患者的长期脏结果至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 类风湿病学 类风湿病学
- 内部医学 内部医学
背景情况:
- 狼性炎 (LN) 是系统性红斑狼的一种严重并发症.
- 慢性病 (CKD) 的进展是LN患者的一个主要问题.
- 肥胖作为LN中CKD风险因素的作用需要进一步调查.
研究的目的:
- 确定肥胖是否是患狼性炎 (LN) 患者慢性病G3 (CKD G3) 的危险因素.
- 为了比较肥胖和非肥胖的LN患者之间的完全缓,发作和CKD G3的比率.
主要方法:
- 对132个经过活检证明的LN病例进行了回顾性审查,其中包括季度数据.
- 肥胖 (BMI ≥30 kg/m2) 和非肥胖患者之间的结局的比较.
- 分析到CKD G3的时间,到炎的时间,以及长期CKD进展风险.
主要成果:
- 肥胖与统计学上较短的CKD G3和病发作时间有关.
- 肥胖显著增加了慢性病进展的长期风险 (HR = 2.72).
- 多变量分析证实肥胖是CKD G3的独立风险因素 (p = .029).
结论:
- 体重指数 (BMI) 30 kg/m2或更高是一个独立的不良预后因素,用于LN中CKD进展.
- 在对LN患者的治疗中,应强调体重控制,以减轻CKD风险.
- 肥胖独立地导致狼性炎中脏结果更差.
相关概念视频
01:21Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:24Nephrotic Syndrome I : Introduction
504
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
504
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
01:26Nephrotic Syndrome II : Assessment and Medical Management
203
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
203